The TGA has informed CMA of the outcomes of compliance reviews for medicines containing the ingredient Euphausia superba (Krill) Oil.
It is CMA’s intention that by highlighting the information contained in this alert it may assist sponsors to review the evidence to support indications for krill oil and voluntarily make any corrective actions that may be required.

Click here to read the Alert